Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with Clinicopathological Characteristics and Chemotherapeutic Outcomes of Lung Cancer.

Huijuan Bi,Lina Yin,Wenhao Fang, Shenglan Song,Shan Wu,Jilu Shen

Laboratory medicine（2022）

引用 5|浏览0

暂无评分

摘要

CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP have good clinical value in the early diagnosis, differential diagnosis, and progression monitoring of lung cancer. The ProGRP and CEA concentrations are beneficial for evaluating the outcome of chemotherapy in SCLC and LAC. The combined detection of multiple biomarkers shows improved clinical value in the early diagnosis of lung cancer.

查看译文

关键词

chemotherapy,cytokeratin 19 fragment,lung cancer,neuron-specific enolase,pro-gastrin-releasing peptide,squamous cell carcinoma antigen

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要